TABLE 4.

Comparison of treatment outcomes in the two study groups at weeks 3 and 9 after therapy commencement

Outcome	Wk 3			Wk 9
	No. (%) of patients		P	No. (%) of patients		Pa
	G-CSF group (n = 20)	Control group (n = 20)		G-CSF group (n = 20)	Control group (n = 20)
Cure	0	0		7 (35)	7 (35)	1.00
Improvement	12 (60)	9 (45)	0.34	8 (40)	4 (20)	0.17
Failure	8 (40)	11 (55)	0.34	5 (25)	9 (45)	0.19

^aχ² test.